Cargando…
Many small steps towards a COVID-19 drug
A large-scale screening campaign has yielded dozens of crystal structures of small molecule fragments that bind to the main protease of SARS-CoV-2. The global research community is encouraged to pursue these as drug discovery starting points for COVID-19.
Autor principal: | Erlanson, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541474/ https://www.ncbi.nlm.nih.gov/pubmed/33028832 http://dx.doi.org/10.1038/s41467-020-18710-3 |
Ejemplares similares
-
It may take many villages, but progress can be made toward HCV elimination among people who inject drugs
por: Page, Kimberly
Publicado: (2023) -
Too many antibiotics for patients with COVID-19 despite low bacterial infections
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023) -
Many happy returns
por: Petsko, Gregory A
Publicado: (2009) -
How many hospitalizations has the COVID-19 vaccination already prevented in São Paulo?
por: Izbicki, Rafael, et al.
Publicado: (2021) -
From emergency response to long-term management: the many faces of the endemic state of COVID-19
por: Contreras, Seba, et al.
Publicado: (2023)